Activation of caspase-8 during N-(4-hydroxyphenyl)retinamide-induced apoptosis in fas-defective hepatoma cells

Hepatology

Volumn 34, Issue 6, 2001, Pages 1119-1127

  You, Kyung Ran ^a   Shin, Myung Nym ^a   Park, Rae Kil ^b   Lee, Seung Ok ^a   Kim, Dae Ghon ^a  

^a Chonbuk National University Medical School   (South Korea)

^b Wonkwang University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ANTIOXIDANT; BENZYLOXYCARBONYLCYSTEINYLGLUTAMYLHISTIDYLASPARTYL FLUOROMETHYL KETONE; BENZYLOXYCARBONYLVALYLALANYLASPARTYL FLUOROMETHYL KETONE; CALPASTATIN; CASPASE 3 INHIBITOR; CASPASE 8; CASPASE 8 INHIBITOR; CASPASE 9; CASPASE 9 INHIBITOR; CASPASE INHIBITOR; CYTOCHROME C; FAS ANTIGEN; FENRETINIDE; ISOLEUCYLGLUTAMYLTHREONYLASPARTALDEHYDE; MITOCHONDRIAL ENZYME; N ACETYLASPARTYLGLUTAMYLVALYLASPARTYL CHLOROMETHYL KETONE; N ACETYLLEUCYLLEUCYLNORLEUCINAL; PROTEIN; PROTEIN BAX; PROTEIN BCL X; PROTEIN BID; PROTEIN CRM A; PROTEIN E1B19K; SERINE PROTEINASE INHIBITOR; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER RESISTANCE; CELL STRAIN; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME RELEASE; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; STRAIN DIFFERENCE;

EID: 0035189501     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.2001.29199     Document Type: Article

References (61)

1. N-(4-Hydroxyphenyl)retinamide, a new retinoid for prevention of breast cancer in the rat
2. Pharmaokinetics of N-4-hydroxyphenyl-retinamide and the effect of its oral administration on plasma retinol concentrations in cancer patients
3. Neuroblastoma cell apoptosis induced by the synthetic retinoid N-(4-hydroxyphenyl)retinamide
4. Differential effects of N-(4-hydroxyphenyl)retinamide and retinoic acid on neuroblastoma cells: Apoptosis versus differentiation
5. Induction of apoptosis by fenretinide (4HPR) in human ovarian carcinoma cells and its association with retinoic acid receptor expression
6. N-(4-hydroxyphenyl)retinamide induces apoptosis of malignant hemopoietic cell lines including those unresponsive to retinoic acid
7. Regulation of apoptosis induced by the retinoid N-(4-hydroxyphenyl) retinamide and effect of deregulated bcl-2
8. Role of antioxidants and intracellular free radicals in retinamide-induced cell death
9. Induction of apoptosis by N-(4-hydroxyphenyl) retinamide and its association with reactive oxygen species, nuclear retinoic acid receptors, and apoptosis-related genes in human prostate carcinoma cells
10. Immunohistochemical detection of Fas antigen in liver tissue of patients with chronic hepatitis C
11. Involvement of the CD95 (APO-1/Fas) receptor and ligand in liver damage
12. Fas antigen expression and its relationship with apoptosis in human hepatocellular carcinoma and noncancerous tissues
13. Resistance to Fas-mediated apoptosis in human hepatoma cells
14. Involvement of the CD95(APO-1/FAS)receptor/ligand system in drug-induced apoptosis in leukemia cells
15. Drug-induced apoptosis in hepatoma cells is mediated by the CD95 (APO-1/Fas) receptor/ligand system and involves activation of wild-type p53
16. The CD95 (APO-1/Fas) system mediates drug-induced apoptosis in neuroblastoma cells
17. Ectopic expression of CHOP (GADD153) induces apoptosis in M1 myeloblastic leukemia cells
18. TRAIL/Apo2L activates c-Jun NH2-terminal kinase (JNK) via caspase-dependent and caspase-independent pathways
19. E1B 19K inhibits Fas-mediated apoptosis through FADD-dependent sequestration of FLICE
20. Toxic bile salts induce rodent hepatocyte apoptosis via direct activation of Fas
21. FLICE, a novel FADD-homologous ICE/CED3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex
22. The cell cycle related differences in susceptibility of HL-60 cells to apoptosis induced by various antitumor agents
23. Apoptosis induced by retinoic acid in Hep 3B cells in vitro
24. Expression and function of the FAS antigen in B chronic lymphocytic leukemia and hairy cell leukemia
25. Construction of a bifunctional mRNA in the mouse by using the internal ribosomal entry site of the encephalomyocarditis virus
26. Apoptosis occurs more frequently in metastatic foci than in primary lesions of human colorectal carcinomas: Analysis by terminal-deoxynucleotidyltransferase-mediated dUTP-biotin nick end labeling
27. Apoptosis in human hepatoma cell lines by chemotherapeutic drugs via Fas-dependent and Fas-independent pathways
28. Target protease specificity of the viral serpin CrmA. Analysis of five caspases
29. Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors
30. Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis
31. Comparison of apoptosis in wild-type and Fas-resistant cells: Chemotherapy-induced apoptosis is not dependent on Fas/Fas ligand interactions
32. Doxorubicin-induced apoptosis in human T-cell leukemia is mediated by caspase-3 activation in a Fas-independent way
33. Anticancer drugs induce caspase-8/FLICE activation and apoptosis in the absence of CD95 receptor/ligand interaction
34. Retinoblastoma and p53 tumor suppressor genes in human hepatoma cell lines
35. c-Jun N-terminal kinase mediates apoptotic signaling induced by N-(4-hydroxyphenyl)retinamide
36. Increase of eramide and induction of mixed apoptosis/necrosis by N-(4-hydroxyphenyl)-retinamide in neuroblastoma cell lines
37. FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis
38. FADD: Essential for embryo development and signaling from some, but not all, inducers of apoptosis
39. Cycloheximide-induced T-cell death is mediated by a Fas-associated death domain-dependent mechanism
40. Cleavage of Bax enhances its cell death function
41. Requirement of caspase3(-like) protease-mediated hydrogen peroxide production for apoptosis induced by various anticancer drugs
42. Involvement of reactive oxygen species in N-(4-hydroxyphenyl)retinamide-induced apoptosis in cervical carcinoma cells
43. Two CD95 (APO-1/Fas) signaling pathways
44. Essential role of the mitochondrial apoptosis-inducing factor in programmed cell death
45. Caspase cleaved BID targets mitochondria and is required for cytochrome c release, while BCL-XL prevents this release but not tumor necrosis factor-R1/Fas death
46. Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-beta
47. Cytochrome c release and apoptosis induced by mitochondrial targeting of nuclear orphan receptor TR3
48. Bax directly induces release of cytochrome c from isolated mitochondria
49. Cytosol-to-membrane redistribution of Bax and Bcl-X(L) during apoptosis
50. 2+ ions
51. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene
52. Caspase-9, Bcl-XL, and Apaf-1 form a ternary complex
53. Bcl-2 prolongs cell survival after Bax-induced release of cytochrome C
54. Injected cytochrome C induces apoptosis
55. Implication of mitochondria-derived reactive oxygen species, cytochrome C and caspase-3 in N-(4-hydroxyphenyl)retinamide-induced apoptosis in cervical carcinoma cells
56. XIAP regulates DNA damage-induced apoptosis downstream of caspase-9 cleavage
57. A conserved X1AP-interaction motif in caspase-9 and Smac/DIABLO regulates caspase activity and apoptosis
58. Control of inducible chemoresistance enhanced anti-tumor therapy through increased apoptosis by inhibition of NF-kappaB
59. Inhibition of NF-kappaB sensitizes human pancreatic carcinoma cells to apoptosis induced by etoposide (VP16) or doxorubicin
60. Essential requirement for caspase-8/FLICE in the initiation of the Fas-induced apoptotic cascade